Exfoliative dermatitis
☆ AI Dermatology — Free Service
In anno 2022 Stiftung Warentest ex Germania provenit, satisfactio consumptoria cum ModelDerm paulo minus fuit quam cum consultationibus telemedicinis solutis.
In anno 2022 Stiftung Warentest ex Germania provenit, satisfactio consumptoria cum ModelDerm paulo minus fuit quam cum consultationibus telemedicinis solutis.
Syndroma cutis rubrae (Red (burning) Skin Syndrome) ― Erythema et squama in toto corpore praecipua indicia dermatitis exfoliativa (Exfoliative dermatitis).
relevance score : -100.0%
ReferencesErythroderma rara est sed gravis conditio cutis. Dum accurata causa saepe ignota est, reactionem medicamentorum vel cancer subiectus incitari potest. Una communis cancer cum dermatitis exfoliativa coniunctus est lymphoma cutaneum T‑cellulare, quod signa per menses vel etiam annos post initium conditionis cutis ostendere non potest. Fere hospitalizatio opus est ad primam aestimationem et curationem. Aegroti cum morbo ex medicamento inducto fere bonam diuturnam prognosis habent, quamquam casus sine causa manifesta tendunt ad cursum recurrentem et remittentem. Prognosis casuum cum cancro coniunctarum typice pendet ex progressu cancri.
Erythroderma is a rare but serious skin condition. While the exact cause is often unknown, it can be triggered by a drug reaction or an underlying cancer. One common cancer linked to exfoliative dermatitis is cutaneous T-cell lymphoma, which might not show symptoms for months or even years after the skin condition starts. Usually, hospitalization is needed for initial assessment and treatment. Patients with drug-induced disease generally have a good long-term outlook, though cases without a clear cause tend to have a recurring and remitting course. The prognosis for cases linked to cancer typically depends on how the cancer progresses.
Erythroderma is a rare but serious skin condition. While the exact cause is often unknown, it can be triggered by a drug reaction or an underlying cancer. One common cancer linked to exfoliative dermatitis is cutaneous T-cell lymphoma, which might not show symptoms for months or even years after the skin condition starts. Usually, hospitalization is needed for initial assessment and treatment. Patients with drug-induced disease generally have a good long-term outlook, though cases without a clear cause tend to have a recurring and remitting course. The prognosis for cases linked to cancer typically depends on how the cancer progresses.
Dermatitis exfoliativa est morbus cutaneus inflammatorius cum rubore et desquamatione qui afficit fere totam superficiem corporis. Haec conditio signum est variarum conditionum cutanearum subiectarum, sicut psoriasis, dermatitis contactus, dermatitis seborrheica, lichen planus, pityriasis rubra pilaris, vel responsio ad medicamenta, exempli gratia steroides topici.
It characteristically demonstrates diffuse erythema and scaling of greater than 90% of the body surface area. It is a reaction pattern and cutaneous manifestation of a myriad of underlying ailments, including psoriasis and eczema, or a reaction to the consumption of certain drugs.
It characteristically demonstrates diffuse erythema and scaling of greater than 90% of the body surface area. It is a reaction pattern and cutaneous manifestation of a myriad of underlying ailments, including psoriasis and eczema, or a reaction to the consumption of certain drugs.
Frequentissima causa erythrodermae est exacerbatio morbi cutanei subiecti, qualia sunt psoriasis, dermatitis contactus (contact dermatitis), dermatitis seborrheica (seborrheic dermatitis), lichen planus, pityriasis rubra pilaris, aut reactio medicamentosa (drug reaction), exempli gratia ex steroidibus topicis (topical steroids). Manifestatio primaria rarior est et in casibus lymphomatis cutanei T‑cellulae (cutaneous T‑cell lymphoma) solet apparere. Quia interest ad distinctionem lymphomatis cutanei T‑cellulae, biopsis conficitur.